137 related articles for article (PubMed ID: 38849683)
41. Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer.
Hou S; Pan Z; Hao X; Hang Q; Ding Y
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680311
[TBL] [Abstract][Full Text] [Related]
42. Treatments for resectable esophageal cancer: from traditional systemic therapy to immunotherapy.
Yan Y; Feng X; Li C; Lerut T; Li H
Chin Med J (Engl); 2022 Sep; 135(18):2143-2156. PubMed ID: 36525602
[TBL] [Abstract][Full Text] [Related]
43. RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
Lorenzen S; Biederstädt A; Ronellenfitsch U; Reißfelder C; Mönig S; Wenz F; Pauligk C; Walker M; Al-Batran SE; Haller B; Hofheinz RD
BMC Cancer; 2020 Sep; 20(1):886. PubMed ID: 32933498
[TBL] [Abstract][Full Text] [Related]
44. Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer.
Scheufele F; Hartmann D; Friess H
Transl Gastroenterol Hepatol; 2019; 4():32. PubMed ID: 31231699
[TBL] [Abstract][Full Text] [Related]
45. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
46. [Chemotherapy and Radio-Chemotherapy of Locally Advanced Esophageal Cancer].
Wille K; Mann C; Berlth F; Fetzner UK; Othmann K; Mönig SP
Ther Umsch; 2022 Apr; 79(3-4):189-194. PubMed ID: 35440193
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the safety and effectiveness of neoadjuvant combined chemoimmunotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective single-arm cohort study.
Xia P; Li P; Wu S; Wang Y; Ye P; Zhang C; Hu J; Kidane B; Lampridis S; Velotta JB; Wakefield CJ; Zhu L; Wang L
Ann Transl Med; 2022 Sep; 10(18):991. PubMed ID: 36267734
[TBL] [Abstract][Full Text] [Related]
48. History and current situation of neoadjuvant treatment for locally advanced esophageal cancer.
Li J; Ma S
Thorac Cancer; 2021 Sep; 12(17):2293-2299. PubMed ID: 34254738
[TBL] [Abstract][Full Text] [Related]
49. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Shitara K; Rha SY; Wyrwicz LS; Oshima T; Karaseva N; Osipov M; Yasui H; Yabusaki H; Afanasyev S; Park YK; Al-Batran SE; Yoshikawa T; Yanez P; Dib Bartolomeo M; Lonardi S; Tabernero J; Van Cutsem E; Janjigian YY; Oh DY; Xu J; Fang X; Shih CS; Bhagia P; Bang YJ;
Lancet Oncol; 2024 Feb; 25(2):212-224. PubMed ID: 38134948
[TBL] [Abstract][Full Text] [Related]
50. The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan.
Tsukada Y; Higashi T; Shimada H; Kikuchi Y; Terahara A
Int J Clin Oncol; 2018 Feb; 23(1):81-91. PubMed ID: 28795280
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of Clinical and Safety Outcomes of Neoadjuvant Immunotherapy Combined With Chemotherapy for Patients With Resectable Esophageal Cancer: A Systematic Review and Meta-analysis.
Ge F; Huo Z; Cai X; Hu Q; Chen W; Lin G; Zhong R; You Z; Wang R; Lu Y; Wang R; Huang Q; Zhang H; Song A; Li C; Wen Y; Jiang Y; Liang H; He J; Liang W; Liu J
JAMA Netw Open; 2022 Nov; 5(11):e2239778. PubMed ID: 36322089
[TBL] [Abstract][Full Text] [Related]
52. A pilot phase II study of neoadjuvant triplet chemotherapy regimen in patients with locally advanced resectable colon cancer.
Zhou H; Song Y; Jiang J; Niu H; Zhao H; Liang J; Su H; Wang Z; Zhou Z; Huang J
Chin J Cancer Res; 2016 Dec; 28(6):598-605. PubMed ID: 28174488
[TBL] [Abstract][Full Text] [Related]
53. What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer?
Altorki N; Harrison S
Ann Cardiothorac Surg; 2017 Mar; 6(2):167-174. PubMed ID: 28447006
[TBL] [Abstract][Full Text] [Related]
54. Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching.
Jing SW; Zhai C; Zhang W; He M; Liu QY; Yao JF; Wang R; Tian ZQ; Wang J; Liu JF
Front Immunol; 2022; 13():970534. PubMed ID: 36275724
[TBL] [Abstract][Full Text] [Related]
55. Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study.
Liu J; Li J; Lin W; Shao D; Depypere L; Zhang Z; Li Z; Cui F; Du Z; Zeng Y; Jiang S; He P; Gu X; Chen H; Zhang H; Lin X; Huang H; Lv W; Cai W; Liang W; Liang H; Jiang W; Wang W; Xu K; Cai W; Wu K; Lerut T; Fu J; He J
Int J Cancer; 2022 Jul; 151(1):128-137. PubMed ID: 35188268
[TBL] [Abstract][Full Text] [Related]
56. Camrelizumab in combination with neoadjuvant chemotherapy in resectable locally advanced esophageal squamous carcinoma cancer: Results from a retrospective study.
Kang NN; Zheng H; Hu JX; Cui K; Si PP; Ge W
Kaohsiung J Med Sci; 2024 Mar; 40(3):291-295. PubMed ID: 38088519
[TBL] [Abstract][Full Text] [Related]
57. ASO Author Reflections: Treatment Strategies for Locally Advanced Borderline Resectable Esophageal Squamous Cell Carcinoma.
Hong Y
Ann Surg Oncol; 2024 Feb; 31(2):896. PubMed ID: 37962739
[No Abstract] [Full Text] [Related]
58. PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: a retrospective study.
Fang Q; Xu P; Cao F; Wu D; Liu X
Cancer Immunol Immunother; 2023 Dec; 72(12):4161-4168. PubMed ID: 37804437
[TBL] [Abstract][Full Text] [Related]
59. A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal Cancers.
Su X; He HC; Ye ZL; Zhou DL; Liu Q; Yang XH; Long YK; Tang T; Ma JJ; Xu BH; Chen WC; He CY; Yang AK
Front Oncol; 2020; 10():535893. PubMed ID: 33178574
[TBL] [Abstract][Full Text] [Related]
60. [The role of neoadjuvant therapy in multimodality treatment of locally advanced esophageal squamous cell carcinoma: perspective from the NEOCRTEC5010 trial].
Guo XF; Fang WT
Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):646-650. PubMed ID: 34192855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
